The stock is in a recovery phase after a sharp downtrend, with a 1-year price change of +15.57% but a 3-month change of -3.59%. The current price of $146.34 sits at 81% of its 52-week range ($116.77–$180.49), indicating it has bounced from the lows but remains well below the highs. This positioning suggests the stock is in a rebuilding phase, with potential upside if momentum continues but still vulnerable to renewed selling pressure. Short-term momentum is strongly positive, with a 1-month price change of +15.27% versus a 3-month decline of -3.59%, signaling a sharp reversal from the May selloff. The 1-month relative strength of +11.20% versus the S&P 500 indicates the stock is outperforming the market in the near term, but the 3-month relative strength of -14.70% shows it has lagged over the medium term. This divergence suggests the recent rally may be a mean-reversion bounce rather than a sustainable uptrend, warranting caution. Key support lies near the 52-week low of $116.77, while resistance is at the 52-week high of $180.49. A breakout above $180.49 would signal a resumption of the long-term uptrend, while a breakdown below $116.77 could indicate further downside. The stock's beta of 1.231 implies it is 23% more volatile than the S&P 500, meaning it tends to amplify market moves, which is important for risk management.

Revenue in the most recent quarter (Q4 2025) was $2.689 billion, up 3.49% year-over-year, but this represents a deceleration from the prior quarter's $2.732 billion and a decline from the $2.846 billion in Q2 2025. The Access Equipment segment contributed $1.110 billion, Vocational $968 million, and Corporate $23 million, showing a diversified but mixed revenue base. The multi-quarter trend shows revenue peaking in mid-2025 and then flattening, suggesting growth is stalling, which is a concern for the investment case. Net income in Q4 2025 was $133.8 million, down from $196.2 million in Q3 2025 and $204.8 million in Q2 2025, reflecting a sharp 35% sequential decline. Gross margin compressed to 15.77% in Q4 2025 from 17.50% in Q3 and 19.20% in Q2, indicating margin pressure. Operating margin fell to 7.88% from 9.69% in Q3, and net margin dropped to 4.98% from 7.30%. The company remains profitable, but the trajectory is deteriorating, which is a red flag for earnings quality. The balance sheet is healthy with a debt-to-equity ratio of 0.34 and a current ratio of 1.94, indicating adequate liquidity. Free cash flow for the trailing twelve months was $603.9 million, but the most recent quarter showed a negative free cash flow of -$435.2 million due to working capital swings. ROE stands at 14.28%, which is respectable, but the negative free cash flow in the latest quarter raises concerns about cash generation sustainability.